Neah Likhite

Neah Likhite has a diverse work experience in the field of scientific research. Neah started their career as a Research Intern at the Advanced Center for the Treatment, Research and Education in Cancer in 2007, where they developed protein solubilization and isolation techniques for biomarker detection. Neah then worked as a Junior Research Fellow at the Department of Biotechnology, University of Pune from 2008 to 2009, where they were advised by Dr. J. K.

Neah then pursued a Ph.D. at the University at Buffalo (UB) from 2009 to 2016. Their thesis project focused on investigating the role of protein arginine methylation in GPCR signaling and RNA polymerase III transcription. Neah made significant contributions to the project by demonstrating that the human D2 dopamine receptor and a subunit of RNA Polymerase III undergo arginine methylation, which promotes their respective functions.

Following their Ph.D., Neah joined The University of Texas Health Science Center at Houston (UTHealth) as a Research Fellow from 2016 to 2019. Their research in this role involved investigating the role of orphan nuclear receptors in angiogenesis to identify new drug targets for diabetes, ischemia, and retinopathy. Neah notably demonstrated that the estrogen-related receptor regulates angiogenesis in endothelial cells.

In 2019, Neah joined Omega Therapeutics as a Scientist. In this role, they performed mechanism of action studies on lead effectors and contributed to the understanding of the role of certain molecules in biological processes. Neah stayed with Omega Therapeutics until 2020.

Most recently, in 2020, Neah Likhite joined Jnana Therapeutics as a Senior Scientist, where they continue their scientific research career. Specific details about their role and responsibilities at Jnana Therapeutics are not provided in the given information.

Neah Likhite began their education in 2004 at the University of Mumbai, where they earned a Bachelor of Science (B.Sc.) degree in Biotechnology in 2006. Neah then pursued a Master of Science (M.Sc.) degree in Biotechnology at the same institution from 2006 to 2008. In 2009, Neah enrolled at the University at Buffalo, where they obtained a Master of Science (M.S.) degree in Biology with a focus on Transcriptional Regulation, which they completed in 2011. Continuing their academic journey, Neah went on to earn a Doctor of Philosophy (Ph.D.) from the University at Buffalo between 2011 and 2016, specializing in Arginine methylation in GPCR signaling and RNA Polymerase III transcription. From 2016 to 2019, Neah pursued a postdoctoral fellowship at The University of Texas Health Science Center at Houston (UTHealth Houston) in the field of Metabolic and Degenerative diseases.